Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Hypertension. 2011 Jun 13;58(2):197–204. doi: 10.1161/HYPERTENSIONAHA.110.164392

Figure 2.

Figure 2

Two-week relaxin treatment prevents the development of renal injury in ANG II but not L-NAME induced hypertension. Effects of ANGII and relaxin on (A) the urinary excretion of albumin and (B) glomerular injury and effects of L-NAME and relaxin on (C) the urinary excretion of albumin and (D) glomerular injury. Values are mean ± SEM, n=8-11. * p<0.05 vs control.